Lung Cancer Trial, By Invitation NCT07373951 Sponsor: Ming Yang Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, By Invitation

NCT07373951
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who were 18 years of age or older at the time of surgery to remove a brain metastasis (a cancer spread to the brain), and whose cancer has been confirmed by laboratory testing to be non-small cell lung cancer (NSCLC), with surgery on the brain metastasis serving as the starting point for the study.
  • People for whom a brain MRI scan taken before surgery is available, including at minimum two specific types of scan: one taken with a contrast dye (T1CE) and one called a FLAIR scan.
  • People for whom genetic testing results (EGFR and ALK status) from the removed brain tissue are available, obtained through a type of detailed laboratory test called next-generation sequencing.
  • People whose MRI scan images are of sufficient quality for analysis, meaning the brain is adequately shown and there are no severe image distortions.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People for whom one or both of the required scan types (T1CE or FLAIR) are missing, or whose scan images are too poor in quality to be usable due to severe distortions or movement during the scan.
  • People for whom the required genetic testing results for EGFR and/or ALK from the brain metastasis tissue are missing or cannot be confirmed.
  • People whose original cancer type is uncertain or has been confirmed to be something other than non-small cell lung cancer, or people who received prior treatment to the brain that significantly changed how the tumour appeared on the MRI before the study scan, in a way that cannot be reliably accounted for by the study investigators (for example, radiation therapy given immediately before the MRI) (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Ming Yang
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
1 April 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Patient-level AUC for driver status (External Validation)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov